Status: retired, Primitive. Date: 31-Mar 2015. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 176123011000036110 | glycerophosphate manganese | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 176124011000036112 | glycerophosphate manganese (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| glycerophosphate manganese | is modification of | glycerophosphoric acid | false | Inferred relationship | Some | ||
| glycerophosphate manganese | Is a | medicinal substance | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| glycerophosphate calcium 88 mg/10 mL (equivalent to 16.72 mg of calcium) + glycerophosphate ferric 21.75 mg/10 mL (equivalent to 3.3 mg of elemental iron) + glycerophosphate manganese 2 mg/10 mL (equivalent to 488 microgram of manganese) + glycerophosphate potassium 10.61 mg/10 mL (equivalent to 2.74 mg of potassium) + glycerophosphate sodium 10.61 mg/10 mL (equivalent to 1.59 mg of sodium) + liver extract 38.67 mg/10 mL + thiamine hydrochloride 1.19 mg/10 mL oral liquid | has Australian BoSS | False | glycerophosphate manganese | Inferred relationship | Some | 1520056194 |
| Hepasol oral liquid: solution, 10 mL | has Australian BoSS | False | glycerophosphate manganese | Inferred relationship | Some | 102644350 |
Reference Sets
Concept inactivation indicator reference set
FHIR